Neeland I, de Gregorio L, Zagury R, Ahren B, Neutel J, Darimont C
Metabolites. 2025; 15(1).
PMID: 39852403
PMC: 11767963.
DOI: 10.3390/metabo15010061.
Aung N
Clin Diabetes. 2025; 43(1):161-164.
PMID: 39829699
PMC: 11739343.
DOI: 10.2337/cd24-0099.
Bassin S, Srinath R
Am J Lifestyle Med. 2025; 19(1):147-161.
PMID: 39822318
PMC: 11733108.
DOI: 10.1177/15598276231180541.
Pabla P, Mallinson J, Nixon A, Keeton M, Cooper S, Marshall M
Am J Clin Nutr. 2024; 121(2):232-245.
PMID: 39732398
PMC: 11863336.
DOI: 10.1016/j.ajcnut.2024.12.022.
Park J, Yoo J, Han J
Nutrients. 2024; 16(22).
PMID: 39599757
PMC: 11597832.
DOI: 10.3390/nu16223972.
Postprandial Glucose and Insulin Response to Meal Sequence Among Healthy UAE Adults: A Randomized Controlled Crossover Trial.
Shaheen A, Sadiya A, Mussa B, Abusnana S
Diabetes Metab Syndr Obes. 2024; 17:4257-4265.
PMID: 39559800
PMC: 11572438.
DOI: 10.2147/DMSO.S468628.
The Contribution of Postprandial Glucose Levels to Hyperglycemia in Type 2 Diabetes Calculated from Continuous Glucose Monitoring Data: Real World Evidence from the DIALECT-2 Cohort.
den Braber N, Vollenbroek-Hutten M, Teunissen S, Oosterwijk M, Kappert K, Laverman G
Nutrients. 2024; 16(20).
PMID: 39458552
PMC: 11510104.
DOI: 10.3390/nu16203557.
Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide.
Jalleh R, Plummer M, Marathe C, Umapathysivam M, Quast D, Rayner C
J Clin Endocrinol Metab. 2024; 110(1):1-15.
PMID: 39418085
PMC: 11651700.
DOI: 10.1210/clinem/dgae719.
Manipulation of Post-Prandial Hyperglycaemia in Type 2 Diabetes: An Update for Practitioners.
Shibib L, Al-Qaisi M, Guess N, Miras A, Greenwald S, Pelling M
Diabetes Metab Syndr Obes. 2024; 17:3111-3130.
PMID: 39206417
PMC: 11350065.
DOI: 10.2147/DMSO.S458894.
Impacts of dietary animal and plant protein on weight and glycemic control in health, obesity and type 2 diabetes: friend or foe?.
Anjom-Shoae J, Feinle-Bisset C, Horowitz M
Front Endocrinol (Lausanne). 2024; 15:1412182.
PMID: 39145315
PMC: 11321983.
DOI: 10.3389/fendo.2024.1412182.
Electronic Glycemic Management System Improved Glycemic Control and Reduced Complications in Patients With Diabetes Undergoing Coronary Artery Bypass Surgery: A Randomized Controlled Trial.
Camara de Souza A, Toyoshima M, Cukier P, Lottenberg S, Bolta P, Lima E
J Diabetes Sci Technol. 2024; :19322968241268352.
PMID: 39096188
PMC: 11571349.
DOI: 10.1177/19322968241268352.
2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association.
Moon J, Kang S, Choi J, Lee K, Moon J, Chon S
Diabetes Metab J. 2024; 48(4):546-708.
PMID: 39091005
PMC: 11307112.
DOI: 10.4093/dmj.2024.0249.
Ultra rapid lispro improves postprandial glucose control versus lispro in combination with basal insulin: a study based on CGM in type 2 diabetes in China.
Yuan L, Luo Y, Luo Y, Ding B, Zhang P, Ma J
Front Endocrinol (Lausanne). 2024; 15:1364585.
PMID: 38774225
PMC: 11106447.
DOI: 10.3389/fendo.2024.1364585.
The role of low glycemic index and load diets in medical nutrition therapy for type 2 diabetes: an update.
Gerontiti E, Shalit A, Stefanaki K, Kazakou P, Karagiannakis D, Peppa M
Hormones (Athens). 2024; 23(4):655-665.
PMID: 38750304
PMC: 11519289.
DOI: 10.1007/s42000-024-00566-7.
Glycemic variability is associated with sural nerve conduction velocity in outpatients with type 2 diabetes: Usefulness of a new point-of-care device for nerve conduction studies.
Morita M, Sada K, Hidaka S, Ogawa M, Shibata H
J Diabetes Investig. 2024; 15(8):1075-1083.
PMID: 38685597
PMC: 11292385.
DOI: 10.1111/jdi.14211.
Continuous glucose monitoring for the routine care of type 2 diabetes mellitus.
Ajjan R, Battelino T, Cos X, Del Prato S, Philips J, Meyer L
Nat Rev Endocrinol. 2024; 20(7):426-440.
PMID: 38589493
DOI: 10.1038/s41574-024-00973-1.
Gastric emptying of a glucose drink is predictive of the glycaemic response to oral glucose and mixed meals, but unrelated to antecedent glycaemic control, in type 2 diabetes.
Xiang C, Sun Y, Luo Y, Xie C, Huang W, Sun Z
Nutr Diabetes. 2024; 14(1):13.
PMID: 38589353
PMC: 11001856.
DOI: 10.1038/s41387-024-00264-8.
Impact of the timing of metformin administration on glycaemic and glucagon-like peptide-1 responses to intraduodenal glucose infusion in type 2 diabetes: a double-blind, randomised, placebo-controlled, crossover study.
Xie C, Iroga P, Bound M, Grivell J, Huang W, Jones K
Diabetologia. 2024; 67(7):1260-1270.
PMID: 38561463
PMC: 11153273.
DOI: 10.1007/s00125-024-06131-6.
Immediate Impact of Switching from Dipeptidyl Peptidase 4 (DPP4) Inhibitors to Low-Dose (0.3 mg) Liraglutide on Glucose Profiles: A Retrospective Observational Study.
Terui S, Igari M, Tsuno T, Okuyama T, Inoue R, Kyohara M
Diabetes Ther. 2024; 15(5):1139-1153.
PMID: 38494572
PMC: 11043256.
DOI: 10.1007/s13300-024-01557-y.
extract reduces serum inflammatory markers and postprandial hyperglycemia in healthy but borderline participants with overweight and glycemia in the normal/prediabetes range: a randomized, double-blind, and placebo-controlled trial.
Uchio R, Okuda-Hanafusa C, Sakaguchi H, Saji R, Muroyama K, Murosaki S
Front Nutr. 2024; 11:1324196.
PMID: 38347961
PMC: 10859506.
DOI: 10.3389/fnut.2024.1324196.